Cutaneous Meta
Cutaneous Meta
Cutaneous Meta
Case Report
Cutaneous Metastases from Lung Adenocarcinoma
1
Department of Dermatology, Dermatology Hospital, Southern Medical University, Guangzhou, China
2
Department of Dermatology, Guangdong Provincial Dermatology Hospital, Guangzhou, China
Copyright © 2020 Yu Wang and Ruzeng Xue. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Cutaneous metastases are unusual presenting symptoms of lung cancer. Therefore, they are prone to be misdiagnosed and missed.
The report describes a case of a forty-nine-year-old female with painful zosteriform rashes showing multiple vesicle-like papules
localized on the left breast for 10 days. The patient had been diagnosed as lung adenocarcinoma at the department of oncology one
year ago. Skin biopsy revealed blue nodular lesions in the dermis, composed of clustered heterogeneous tumor cells with glandular
formation. Immunohistochemical stains confirmed the diagnosis of metastatic lung adenocarcinoma.
Figure 1: Zosteriform vesicle-like papules, measuring 0.5–1.0 cm on the left breast. Pink or red, firm, and tender.
Figure 2: Skin biopsy revealed (a) blue nodular lesions infiltrating in the dermis, composed of clustered heterogeneous tumor cells with
glandular formation (H&E, magnification: ×20); (b) some tumor cells were detected within vessels or lymphatic vessels (H&E, magni-
fication: ×40); (c) some cells were blue and transparent, and mitosis was significant (H&E, magnification: ×200).
Figure 3: Immunohistochemical stain highlighting the tumor cells, showing (a) CK-7, (b) EMA, and (c) TTF-1 positive.
skin metastases occurred during the immunotherapy. His- [9] R. Koca, Y. Ustundag, E. Kargi, G. Numanoglu, and
tology shows most commonly adenocarcinoma and then H. C. Altinyazar, “A case with widespread cutaneous me-
squamous/small-cell followed by large-cell carcinoma [1]. tastases of unknown primary origin: grave prognostic finding
Immunohistochemical markers are useful for the identifi- in cancer,” Dermatology Online Journal, vol. 11, no. 1, p. 16,
cation of the primary cancer or when a shorter differential is 2005.
[10] N. A. Babacan, S. Kilickap, S. Sene et al., “A case of multifocal
desired. Anti-TTF is both sensitive and specific for primary
skin metastases from lung cancer presenting with vasculitic-
adenocarcinomas, bronchioalveolar carcinomas, and small- type cutaneous nodule,” Indian Journal of Dermatology,
cell carcinomas when thyroid primary is excluded [8]. vol. 60, p. 213, 2015.
CK7+and CK20− are sensitive but not specific for primary
adenocarcinomas and bronchioalveolar carcinomas. The
CK7+/CK20−tumors usually include the lung, breast, en-
dometrium, ovary, thyroid, salivary gland, and mesotheli-
oma [8, 9].
Treatment of a single solitary skin lesion usually includes
surgery alone or combined with chemotherapy, and/or ra-
diation. If lesions are more disseminated, chemotherapy is
the primary option but may elicit an inadequate response
[10]. Radiation can also be used alone and/or in combination
with chemotherapy, and/or surgery. However, despite the
combination of radiotherapy and chemotherapy, patients
with lung cancer developing cutaneous metastases have a
poor outcome. Mean survival is short, usually 5 to 6 months
after diagnosis of cutaneous metastasis [1].
Conflicts of Interest
The authors declare they have no conflicts of interest.
Acknowledgments
This work was supported by a grant from the National
Natural Science Foundation of China (81903200).
References
[1] T. W. Mollet, C. A. Garcia, and G. Koester, “Skin metastases
from lung cancer,” Dermatology Online Journal, vol. 15, no. 5,
2009.
[2] S. Sun, J. H. Schiller, and A. F. Gazdar, “Lung cancer in never
smokers-a different disease,” Nature Reviews Cancer, vol. 7,
no. 10, pp. 778–790, 2007.
[3] S. Dreizen, H. M. Dhingra, D. F. Chiuten, T. Umsawasdi, and
M. Valdivieso, “Cutaneous and subcutaneous metastases of
lung cancer,” Postgraduate Medicine, vol. 80, no. 8,
pp. 111–116, 1986.
[4] M. Khaja, D. Mundt, R. A. Dudekula et al., “Lung cancer
presenting as skin metastasis of the back and hand: a case
series and literature review,” Case Reports in Oncology, vol. 12,
no. 2, pp. 480–487, 2019.
[5] W. T. McSweeney and K. Tan, “Cutaneous metastases as a
presenting sign of metastatic NSCLC,” Journal of Surgical Case
Reports, vol. 2019, no. 10, 2019.
[6] M. H. Brownstein and E. B. Helwig, “Metastatic tumors of the
skin,” Cancer, vol. 29, no. 5, pp. 1298–1307, 1972.
[7] R. B. McGrath, S. P. Flood, and R. Casey, “Cutaneous me-
tastases in non-small cell lung cancer,” BMJ Case Reports,
vol. 2014, 2014.
[8] V. Jerome Marson, J. Mazieres, O. Groussard et al., “Ex-
pression of TTF-1 and cytokeratins in primary and secondary
epithelial lung tumours: correlation with histological type and
grade,” Histopathology, vol. 45, no. 2, pp. 125–134, 2004.